In Bold, Smart Move, Merck Makes Roger Perlmutter Its Research Chief, Jettisoning Peter Kim
Roger Perlmutter, who left Merck for Amgen more than a decade ago because he didn't think then-chief executive Ray Gilmartin was moving fast enough to adopt new research-and-development strategies, will return to head the company's research labs.
Roger Perlmutter, who left Merck for Amgen more than a decade ago because he didn't think then-chief executive Ray Gilmartin was moving fast enough to adopt new research-and-development strategies, will return to head the company's research labs.